3B Blackbio

Kilpest_India26 Apr 2024

Healthcare

₹

+18.35 (+2.35%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in 3B Blackbio

3B Blackbio

Healthcare

Kilpest_India26 Apr 2024

₹

+18.35 (+2.35%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2023	D	Dividend Update Record Date and Date of Book Closure for the purpose of Dividend and AGM (As Per BSE Announcement Dated on 29/08/2023)	15-Sep-2023
27-May-2022	D	Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2022, inter alia, have recommended a final dividend of 25% i.e. Rs. 2.5/- per equity share of face value of Rs. 10/ each for the FY 2021-22 which is subject to approval of the shareholders at the ensuring Annual General Meeting.	14-Sep-2022
23-Jun-2021	D	Board alia approved: 1. The Board of Directors of the Company have recommended a final dividend of 100/0, Re.1/- i.e. per equity share of face value of Rs. 10/ each for the FY 2020-21 which is subject to approval of the shareholders at the ensuring Annual General Meeting.	14-Sep-2021
23-Jun-2021	D	Board alia approved: The Board of Directors of the Company have also recommended a special interim dividend of Rs. 8/- per equity share of face value of Rs. 10/ each for the FY 202I-22, being declared, thus taking a total dividend payout of RE 9l- per equity share.	14-Sep-2021
12-Mar-2020	D	The BOD''s of the company consider and approves the interim Dividend of 7% on rs. 10 per equity shares	19-Mar-2020
23-May-2019	D	Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 23, 2019, inter alia, has recommended a dividend of Rs. 0.50/- per share (5% of face value of equity share) for the financial year 2018-19. The payment of dividend is subject to the approval of shareholders in the Annual General Meeting of the Company.	17-Sep-2019
23-May-2018	D	Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2018, inter alia, has recommended dividend of 5% (Rs. 0.50 per fully paid up equity shares of Rs. 10/- each) for the year ended March 31, 2018 subject to approval of shareholders at the ensuring Annual General Meeting of the Company.	17-Sep-2018
29-May-2017	D	Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2017, inter alia, has recommended a dividend of 3% for the year ended March 31, 2017, subject to approval of shareholders at the ensuring Annual General Meeting of the Company.	15-Sep-2017
07-Jun-2011	D	Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2011, inter alia, has transacted the following; Recommend the payment of dividend for the year 2010-11 @ Re. 1/- per share on the equity shares of Rs. 10 /- each (i.e. 10%).	19-Sep-2011
02-Jul-2007	D	Kilpest India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2007, inter alia, has recommended a dividend @ 10% on effective equity share capital of the Company for the F.Y. ended on March 31, 2007.	18-Sep-2007
11-Aug-2023	BC	Standalone and Consolidated Un-Audited Financial Result for the quarter ended on 30th June,2023	01-May-2024
17-Jan-2024	BC	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Fi	09-Feb-2024
31-Oct-2023	BC	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Fi	10-Nov-2023
28-Sep-2023	BC	Allotment of Shares pursuant to Scheme of Amalgamation Outcome of Board Meeting (As Per BSE Announcement Dated on 10/10/2023)	10-Oct-2023
13-Oct-2023	BC	Dhirendra Dubey & PACs	10-Oct-2023

Announcement Date29-May-2023

Ex Dividend Date15-Sep-2023

Dividend(%)25

Announcement Date27-May-2022

Ex Dividend Date14-Sep-2022

Dividend(%)25

Announcement Date23-Jun-2021

Ex Dividend Date14-Sep-2021

Dividend(%)10

Announcement Date23-Jun-2021

Ex Dividend Date14-Sep-2021

Dividend(%)80

Announcement Date12-Mar-2020

Ex Dividend Date19-Mar-2020

Dividend(%)7

Announcement Date23-May-2019

Ex Dividend Date17-Sep-2019

Dividend(%)5

Announcement Date23-May-2018

Ex Dividend Date17-Sep-2018

Dividend(%)5

Announcement Date29-May-2017

Ex Dividend Date15-Sep-2017

Dividend(%)3

Announcement Date07-Jun-2011

Ex Dividend Date19-Sep-2011

Dividend(%)10

Announcement Date02-Jul-2007

Ex Dividend Date18-Sep-2007

Dividend(%)10

No Rights has been declared by Kilpest_India

Book Closure

Record Date	Split Date	Purpose
01-May-2024	-	Standalone and Consolidated Un-Audited Financial Result for the quarter ended on 30th June,2023
09-Feb-2024	-	3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Fi
10-Nov-2023	-	KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Fi
10-Oct-2023	-	Allotment of Shares pursuant to Scheme of Amalgamation Outcome of Board Meeting (As Per BSE Announcement Dated on 10/10/2023)
10-Oct-2023	-	Dhirendra Dubey & PACs

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
3B Blackbio DX Ltd ₹798.50(+18.35/2.35%)	798.50	+18.35	599.52	82.04	24.11	2.84
Shree Pacetronix Ltd ₹243.60(+11.60/5.00%)	243.60	+11.60	87.68	132.02	22.41	7.74
Kovai Medical Center & Hospital Ltd ₹4,193.40(+41.45/1.00%)	4,193.40	+41.45	4,587.58	111.37	29.01	5.87
Chennai Meenakshi Multispeciality Hospital Ltd ₹37.22(-0.23/-0.61%)	37.22	-0.23	27.80	75.15	103.39	155.94
Fortis Malar Hospitals Ltd ₹82.56(+3.93/5.00%)	82.56	+3.93	154.73	65.95	0.00	2.71
Apollo Hospitals Enterprise Ltd ₹6,258.55(-126.75/-1.99%)	6,258.55	-126.75	89,988.35	41.89	90.12	12.34

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	16.96	18.57	13.21	3.32	13.64	17.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	16.96	18.57	13.21	3.32	13.64	17.37
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.47	2.75	2.96	0.54	2.88	2.05
Total Income	19.42	21.31	16.17	3.86	16.51	19.42
Total Expenditure	7.36	9.90	6.52	3.71	6.41	7.94
PBIDT	12.06	11.41	9.65	0.15	10.10	11.48
Interest	0.02	0.04	0.02	0.05	0.05	0.07
PBDT	12.04	11.37	9.63	0.10	10.05	11.41
Depreciation	0.20	0.22	0.18	0.08	0.19	0.17
Tax	2.64	2.67	1.98	0.32	2.18	2.60
Deferred Tax	0.00	0.00	0.00	-0.02	0.00	0.00
Reported Profit After Tax	9.21	8.48	7.47	-0.29	7.68	8.65
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	9.21	8.48	7.47	-0.29	7.68	8.65

EPS (Unit Curr.)	10.75	9.90	8.72	-0.38	8.97	10.09
EPS (Adj) (Unit Curr.)	10.75	9.90	8.72	-0.38	8.97	10.09
Calculated EPS (Unit Curr.)	10.75	9.89	8.72	-0.38	8.97	10.09
Calculated EPS (Adj) (Unit Curr.)	10.75	9.89	8.72	-0.38	8.97	10.09
Calculated EPS (Ann.) (Unit Curr.)	43.00	39.58	34.88	-1.53	35.88	40.38
Calculated EPS (Adj) (Ann.) (Unit Curr.)	43.00	39.58	34.88	-1.53	35.88	40.38
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	8.57	8.57	8.57	7.51	8.57	8.57
Reserve & Surplus	162.68	162.68	162.65	16.44	144.47	144.47
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	71.11	61.44	73.05	4.52	74.05	66.09
PBDTM(%)	70.99	61.23	72.90	3.01	73.68	65.69
PATM(%)	54.30	45.67	56.55	-8.73	56.30	49.80

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	17.67	19.18	14.28	18.11	14.73	17.31
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	17.67	19.18	14.28	18.11	14.73	17.31
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.63	2.75	2.96	1.15	2.88	1.96
Total Income	20.30	21.93	17.24	19.26	17.61	19.27
Total Expenditure	8.79	11.39	7.84	10.65	7.41	8.12
PBIDT	11.50	10.54	9.40	8.62	10.20	11.14
Interest	0.03	0.04	0.02	0.04	0.05	0.07
PBDT	11.47	10.50	9.38	8.57	10.14	11.07
Depreciation	0.32	0.24	0.19	0.21	0.25	0.24
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.64	2.67	1.98	2.52	2.18	2.52
Deferred Tax	0.00	0.00	0.00	0.64	0.00	0.00
Reported Profit After Tax	8.52	7.59	7.21	5.20	7.71	8.31
Minority Interest After NP	-0.21	-0.27	-0.08	0.69	0.99	-0.10
Net Profit after Minority Interest	8.72	7.85	7.29	4.51	6.73	8.41

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	8.72	7.85	7.29	4.51	6.73	8.41

EPS (Unit Curr.)	9.94	8.86	8.41	6.92	9.00	9.70
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	8.57	8.57	8.57	7.51	8.57	8.57

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	65.08	54.95	65.83	47.60	69.25	64.36
PBDTM(%)	64.91	54.74	65.69	47.32	68.84	63.95
PATM(%)	48.22	39.57	50.49	28.71	52.34	48.01

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	7.49	7.49	7.49	7.49	6.39	6.38
Reserves Total	16.73	16.44	15.16	13.29	9.35	9.24
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	24.22	23.93	22.65	20.78	15.74	15.62
Secured Loans	1.12	1.69	0.99	2.13	4.16	3.65
Unsecured Loans	0.91	0.84	1.02	1.39	2.03	2.15
Total Debt	2.03	2.53	2.01	3.52	6.19	5.80
Total Liabilities	26.25	26.46	24.66	24.30	21.93	21.42
APPLICATION OF FUNDS :
Gross Block	7.62	7.54	6.00	5.79	5.78	5.62
Less : Accumulated Depreciation	4.62	4.31	4.03	3.82	3.61	3.32
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	3.00	3.23	1.97	1.97	2.17	2.30
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.09	0.11	0.13	0.20	0.10	0.15
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.60	3.60	3.60	3.60	1.35	1.35
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.04	2.66	2.71	3.22	4.16	3.12
Sundry Debtors	13.70	14.35	14.09	14.15	14.12	14.16
Cash and Bank	0.90	1.85	1.71	0.69	0.62	0.63
Loans and Advances	5.29	5.54	4.42	4.12	4.06	4.13
Total Current Assets	22.94	24.40	22.92	22.17	22.94	22.04
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.51	4.08	3.25	3.22	3.80	3.52
Provisions	0.22	0.15	0.36	0.00	0.32	0.41
Total Current Liabilities	2.73	4.23	3.61	3.22	4.12	3.93
Net Current Assets	20.21	20.17	19.31	18.96	18.82	18.11
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.88	0.91	0.62	0.65	0.65	0.65
Net Deferred Tax	-0.88	-0.91	-0.62	-0.65	-0.65	-0.65
Total Assets	26.03	26.20	24.40	24.08	21.79	21.26
Contingent Liabilities	0.54	4.66	5.07	0.42	0.75	0.52

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	7.49	7.49	7.49	7.49	6.39	6.38
Reserves Total	163.73	145.53	124.56	24.62	16.11	12.00
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	171.22	153.02	132.05	32.11	22.50	18.38
Minority Interest	24.68	19.05	16.22	2.14	0.25	0.15
Secured Loans	1.12	1.69	0.99	2.13	4.16	3.65
Unsecured Loans	0.91	0.84	1.02	1.39	2.03	2.15
Total Debt	2.03	2.53	2.01	3.52	6.19	5.80
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.13	0.00	0.03	0.00	0.00	0.00
Total Liabilities	198.06	174.60	150.31	37.77	28.94	24.33
APPLICATION OF FUNDS :
Gross Block	14.36	11.99	10.51	8.76	8.32	7.52
Less: Accumulated Depreciation	6.56	5.38	5.51	4.89	4.35	3.77
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	7.80	6.61	5.00	3.87	3.97	3.75
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.09	0.11	0.13	0.20	0.10	0.15
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	91.71	92.64	58.81	1.20	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	8.04	7.43	4.87	4.07	4.99	3.67
Sundry Debtors	33.94	29.98	34.79	19.93	18.48	16.48
Cash and Bank	59.21	28.89	35.08	9.38	3.37	1.58
Loans and Advances	13.05	15.24	43.64	5.95	5.28	4.60
Total Current Assets	114.24	81.54	118.38	39.33	32.13	26.34
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	4.59	5.24	3.31	3.74	4.12	3.72
Provisions	8.48	9.97	38.67	2.36	2.27	1.48
Total Current Liabilities	13.07	15.21	41.98	6.10	6.39	5.19
Net Current Assets	101.17	66.33	76.41	33.24	25.73	21.14
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	2.92	2.27	1.24	0.96	1.00	0.88
Net Deferred Tax	-2.92	-2.27	-1.24	-0.96	-1.00	-0.88
Other Assets	0.23	11.19	11.20	0.23	0.14	0.16
Total Assets
Contingent Liabilities	0.19	4.74	5.09	0.42	0.75	0.62

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.85	1.71	0.69	0.62	0.63
Net Cash from Operating Activities	1.65	7.98	2.79	1.10	0.45
Net Cash Used In Investing Activities	-0.02	-1.52	-0.17	-2.45	-0.08
Net Cash Used In Financing Activities	-2.57	-6.31	-1.59	1.42	-0.38
Net Inc./Dec In Cash And Cash Equivalents	-0.95	0.14	1.02	0.07	-0.01
Cash And Cash Equivalents At End Of The Year	0.90	1.85	1.71	0.69	0.62

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

41.29%

FII Shareholding

2.97%

DII Shareholding

1.89%

Public Shareholding

53.85%

**Promoter pledged shareholding 41.29%

About 3B Blackbio DX Ltd

3B Blackbio DX Ltd is in the Healthcare sector, having a market capitalization of Rs. 599.52 crores. It has reported a sales of Rs. 16.96 crores and a net profit of Rs. 9.21 crores for the quarter ended December 2018. The company management includes D K Dubey, D K Dubey,N K Dubey,Shabbar Husain,Mithala Dubey,Navneet Kaur,Abdul Moin Khan,Harihar Prasad Thapak (3B Blackbio DX Ltd) among others.

Chairman

D K Dubey

Registered office

7-C Industrial Area,Govindpura,Bhopal,Madhya Pradesh,462023

FAX :91-0755-2580438

Background

Incorporation Year1972

Face Value₹10

Market Lot1

How to buy 3B Blackbio shares on nse?

To buy 3B Blackbio shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the 3B Blackbio share price today?

The 3B Blackbio shares price on nse is Rs.798.5 today.

What is the market cap of 3B Blackbio shares on BSE ?

The company has a market capitalization of Rs.599.52Cr

What is the PE & PB ratio of 3B Blackbio shares ?

PE is 24.11 and PB is 2.84

What is the 52 Week High and Low of 3B Blackbio shares?

3B Blackbio stock price high: Rs.924 3B Blackbio stock price low: Rs.390